Uterine cervix carcinoma: Recent biological data and update for improving follow-up and treatment

Israel Medical Association Journal

Volumn 14, Issue 11, 2012, Pages 700-704

  Mejía Gómez, Javier ^a   Sastre Garau, Xavier ^a  

^a INSTITUT CURIE   (France)

Author keywords

Cervical cancer; Circulating tumor DNA (ctDNA); Gynecological oncology; Human papillomavirus (HPV); Oncogenes

Indexed keywords

CANCER VACCINE; EPITOPE; NUCLEIC ACID; PROTEIN E6; PROTEIN E7; TRANSCRIPTOME; TUMOR MARKER;

ADENOCARCINOMA; CANCER RECURRENCE; CIRCULATING TUMOR CELL; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; FOLLOW UP; GENOME ANALYSIS; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; INVASIVE CARCINOMA; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MORBIDITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; WORLD HEALTH;

EID: 84870741214     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Kenter GG, Welters MJ, Valentijn AR, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 2009; 361 (19): 1838-47.
2. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12 (2): 186-192.
3. Leibenson L, Banani S, Borer A, et al. Te prevalence of human papillo- mavirus and cervical cytology abnormalities in women infected with human immunodefciency virus in southern Israel. IMAJ Isr Med Assoc J 2011; 13 (1): 34-38.
4. de Cremoux P, de la Rochefordiere A, Savignoni A, et al. Diferent outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. Int J Cancer 2009; 124 (4): 778-782.
5. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2 (5): 342-350.
6. Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89 (2): 213-228.
7. Rosty C, Shefer M, Tsafrir D, et al. Identifcation of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene 2005; 24 (47): 7094-8104.
8. Peter M, Stransky N, Couturier J, et al. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol 2010; 221 (3): 320-330.
9. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Doeberitz MK. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 2002; 21 (3): 4194-26.
10. Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre-Garau X. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 2006; 25 (44): 5985-5993.
11. Reuter S, Bartelmann M, Vogt M, et al. APM-1, a novel human gene, identifed by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc fnger protein with growth inhibitory activity. Embo J 1998; 17 (1): 215-222.
12. Sastre-Garau X, Favre M, Couturier J, Orth G. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. J Gen Virol 2000; 81 (Pt 8): 1983-1993.
13. Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l'homme. C R Seances Soc Biol Fil 1948; 142 (3-4): 241-243.
14. Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008; 14 (9): 985-990.
15. Pornthanakasem W, Shotelersuk K, Termrungruanglert W, Voravud N, Niruthisard S, Mutirangura A. Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer 2001; 1: 2.
16. Tseng CJ, Pao CC, Lin JD, Soong YK, Hong JH, Hsueh S. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol 1999; 17 (5): 1391-1396.
17. Baner J, Nilsson M, Mendel-Hartvig M, Landegren U. Signal amplifcation of padlock probes by rolling circle replication. Nucleic Acids Res 1998; 26 (22): 5073-5078.
18. Chen Z, Feng J, Buzin CH, et al. Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer. PLoS One 2009; 4 (9): e7220.